Agile/Scrum Adoption in Regulated Industries
According to the 2013 State-of-Scrum Report, Agile/Scrum is being practiced in 33% of highly regulated industries like finance, healthcare, insurance…
According to the 2013 State-of-Scrum Report, Agile/Scrum is being practiced in 33% of highly regulated industries like finance, healthcare, insurance…
Over the last ten years, the way that the pharmaceutical industry is expected to deliver new drug products to market…
As digital technology plays an increasingly important part in our everyday lives, it comes as no surprise that it has…
Clinical trials are the experimental foundation on which modern medicine is built. Human medicines cannot be sold without permission from…
Mobile health (mHealth) may be the buzzword of today, but unlike many other buzzwords, this one will not be just…
Pyoderma gangrenosum (PG) is a rare and serious skin disease in which a painful nodule breaks down to form progressive…
The availability of generic medication is an important issue in the ASEAN region. The regulatory requirements of various countries of…
The clinical monitoring cost is one of the major costs and accounts for one-third of the overall cost of clinical…
The year 2015 marks the 10th anniversary of the release of two ICH Harmonised Tripartite Guidelines that have governed the…
In recent years, numerous pharmaceutical and biotechnology companies have undertaken development programmes intended to assess the efficacy of various pro-cognitive…